These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15863206)

  • 1. Analysis of HFE and TFR2 gene mutations in patients with acute leukemia.
    Veneri D; Franchini M; Krampera M; de Matteis G; Solero P; Pizzolo G
    Leuk Res; 2005 Jun; 29(6):661-4. PubMed ID: 15863206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of HFE and non-HFE gene mutations in Brazilian patients with hemochromatosis.
    Bittencourt PL; Marin ML; Couto CA; Cançado EL; Carrilho FJ; Goldberg AC
    Clinics (Sao Paulo); 2009; 64(9):837-41. PubMed ID: 19759876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
    Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
    Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HFE gene mutations an Apulian population: allele frequencies.
    Pietrapertosa A; Vitucci A; Campanale D; Palma A; Renni R; Delios G; Tannoia N
    Eur J Epidemiol; 2003; 18(7):685-9. PubMed ID: 12952143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload.
    De Gobbi M; Daraio F; Oberkanins C; Moritz A; Kury F; Fiorelli G; Camaschella C
    Haematologica; 2003 Apr; 88(4):396-401. PubMed ID: 12681966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis.
    Del-Castillo-Rueda A; Moreno-Carralero MI; Cuadrado-Grande N; Alvarez-Sala-Walther LA; Enríquez-de-Salamanca R; Méndez M; Morán-Jiménez MJ
    Gene; 2012 Oct; 508(1):15-20. PubMed ID: 22890139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular diagnosis of hereditary hemochromatosis: application of a newly-developed reverse-hybridization assay in the South African population.
    Kotze MJ; de Villiers JN; Bouwens CS; Warnich L; Zaahl MG; van der Merwe S; Oberkanins C
    Clin Genet; 2004 Apr; 65(4):317-21. PubMed ID: 15025725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hfe mutations and iron overload in patients with alcoholic liver disease.
    Costa-Matos L; Batista P; Monteiro N; Henriques P; Girão F; Carvalho A
    Arq Gastroenterol; 2013; 50(1):35-41. PubMed ID: 23657305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
    Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
    Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
    Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility of HFE variants in Spanish patients: association with HLA alleles and role in susceptibility to acute lymphoblastic leukemia.
    Rodríguez-López R; Donoso M; Fernández-Cavada M; González LM; Margallo A; Corral C; Gallego M; García de Cáceres MT; Herrera T; González C; Vagace JM; Gervasini G
    Gene; 2013 Feb; 514(1):31-5. PubMed ID: 23178241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of the HFE gene among Turkish hereditary hemochromatosis patients.
    Simsek H; Balaban YH; Yilmaz E; Sumer H; Buyukasik Y; Cengiz C; Ozcebe O; Hascelik G; Tatar G
    Ann Hematol; 2005 Oct; 84(10):646-9. PubMed ID: 15871018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutation.
    Mattman A; Huntsman D; Lockitch G; Langlois S; Buskard N; Ralston D; Butterfield Y; Rodrigues P; Jones S; Porto G; Marra M; De Sousa M; Vatcher G
    Blood; 2002 Aug; 100(3):1075-7. PubMed ID: 12130528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis.
    Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S
    Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary hemochromatosis in a Brazilian university hospital in São Paulo State (1990-2000).
    Martinelli AL; Filho R; Cruz S; Franco R; Tavella M; Secaf M; Ramalho L; Zucoloto S; Rodrigues S; Zago M
    Genet Mol Res; 2005 Mar; 4(1):31-8. PubMed ID: 15841433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferrin receptor-2 (TFR2) mutation Y250X in Alabama Caucasian and African American subjects with and without primary iron overload.
    Barton EH; West PA; Rivers CA; Barton JC; Acton RT
    Blood Cells Mol Dis; 2001; 27(1):279-84. PubMed ID: 11358388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of HFE H63D, S65C, and C282Y mutations in patients with iron overload and controls from Toledo, Spain.
    de Diego C; Murga MJ; Martínez-Castro P
    Genet Test; 2004; 8(3):263-7. PubMed ID: 15727249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron overload in acute myeloid leukemia patients is not related to HFE and TFR2 gene mutations.
    Veneri D; Franchini M; Zanetti F; Krampera M; de Matteis G; Pizzolo G
    Haematologica; 2003 Sep; 88(9):1069-70. PubMed ID: 12969816
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of HFE polymorphisms on cardiac iron overload in patients with beta-thalassemia major.
    Turedi A; Oymak Y; Meşe T; Yaman Y; Bayraktaroglu S; Alpman A; Ozkinay F; Aydınok Y; Vergin C
    Pediatr Hematol Oncol; 2013 Nov; 30(8):755-60. PubMed ID: 24087894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.